IL314135A - Serpin peptides and methods of using the same - Google Patents

Serpin peptides and methods of using the same

Info

Publication number
IL314135A
IL314135A IL314135A IL31413524A IL314135A IL 314135 A IL314135 A IL 314135A IL 314135 A IL314135 A IL 314135A IL 31413524 A IL31413524 A IL 31413524A IL 314135 A IL314135 A IL 314135A
Authority
IL
Israel
Prior art keywords
seraphine
peptides
methods
seraphine peptides
Prior art date
Application number
IL314135A
Other languages
English (en)
Hebrew (he)
Original Assignee
Serpin Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serpin Pharma Llc filed Critical Serpin Pharma Llc
Publication of IL314135A publication Critical patent/IL314135A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL314135A 2022-01-05 2022-12-30 Serpin peptides and methods of using the same IL314135A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263266444P 2022-01-05 2022-01-05
PCT/US2022/082669 WO2023133078A2 (en) 2022-01-05 2022-12-30 Serpin peptides and methods of using the same

Publications (1)

Publication Number Publication Date
IL314135A true IL314135A (en) 2024-09-01

Family

ID=87074167

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314135A IL314135A (en) 2022-01-05 2022-12-30 Serpin peptides and methods of using the same

Country Status (8)

Country Link
US (2) US20250161419A1 (cg-RX-API-DMAC7.html)
EP (1) EP4460322A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025503607A (cg-RX-API-DMAC7.html)
CN (1) CN118804758A (cg-RX-API-DMAC7.html)
AU (1) AU2022431253A1 (cg-RX-API-DMAC7.html)
CA (1) CA3247129A1 (cg-RX-API-DMAC7.html)
IL (1) IL314135A (cg-RX-API-DMAC7.html)
WO (1) WO2023133078A2 (cg-RX-API-DMAC7.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016317726B2 (en) * 2015-08-28 2022-05-26 Serpin Pharma, Llc Methods for treatment of diseases
EP3402572B1 (en) * 2016-01-13 2022-03-16 Children's Hospital Medical Center Compositions and methods for treating allergic inflammatory conditions
CA3134610A1 (en) * 2018-04-09 2019-10-17 Yale University Bifunctional small molecules to target the selective degradation of circulating proteins
US20240342293A1 (en) * 2019-10-10 2024-10-17 Yale University Engineered antibodies as molecular degraders through cellular receptors
WO2021092050A1 (en) * 2019-11-04 2021-05-14 Azitra Inc Compositions and methods for treatment or prevention of skin diseases and disorders with lekti
EP4789728A2 (en) * 2020-07-06 2026-08-12 Serpin Pharma, LLC Peptides and methods of using the same
BR112023016690A2 (pt) * 2021-02-22 2023-11-14 Univ Yale Degradadores bifuncionais direcionados e métodos usando os mesmos

Also Published As

Publication number Publication date
JP2025503607A (ja) 2025-02-04
EP4460322A2 (en) 2024-11-13
CA3247129A1 (en) 2023-07-13
US20250161419A1 (en) 2025-05-22
CN118804758A (zh) 2024-10-18
WO2023133078A3 (en) 2023-08-17
EP4460322A4 (en) 2026-02-25
WO2023133078A2 (en) 2023-07-13
AU2022431253A1 (en) 2024-07-25
US20230406906A1 (en) 2023-12-21

Similar Documents

Publication Publication Date Title
DK4232463T3 (da) Interleukin-2-fc-fusionsproteiner og fremgangsmåder til anvendelses
IL292871A (en) Activatable cytokine polypeptides and methods of use thereof
IL282177A (en) Protein tyrosine-tyrosine analogs and methods of using the same
IL284640A (en) Pcsk9 inhibitors and methods of use thereof
IL284661A (en) Pcsk9 inhibitors and methods of use thereof
IL292877A (en) Angiotensinogen (agt) irna compositions and methods of use thereof
EP4089115A4 (en) Anti-tigit antibodies and usage method
EP4472967A4 (en) Iraqi Degradation Agents and Their Uses
IL285401A (en) Anti-clec2d antibodies and methods of use thereof
DK3966207T3 (da) Phenylaminopyrimidinamid-autophagi-hæmmere og fremgangsmåder til anvendelse deraf
DK3966206T3 (da) Heteroarylaminopyrimidinamid-autophagihæmmere og fremgangsmåder til anvendelse deraf
DK3892628T3 (da) Ultra-langtidsvirkende insulin-fc-fusionsproteiner og fremgangsmåder til anvendelse
DK4267105T3 (da) Antistofsammensætninger og fremgangsmåder til anvendelse deraf
DK4073098T5 (da) Ultralangtidsvirkende insulin-Fc-fusionsproteiner og fremgangsmåder til anvendelse
IL290233A (en) Antigen-binding protein constructs and uses thereof
EP4069274A4 (en) PEPTIDE CONJUGATES AND METHODS OF USE
IL284683A (en) Acute treatment and rapid treatment of headache using anti-cgrp antibodies
DK4200018T3 (da) Anti-par-2-antistoffer og fremgangsmåder til anvendelse deraf
IL288310A (en) Cot modulators and methods of use thereof
EP4499068A4 (en) Iraqi Degradation Agents and Their Uses
EP4499149A4 (en) PROTEIN DEGRADING AGENTS AND THEIR USES
IL311301A (en) Anti-siglec-6 antibodies and methods of use thereof
IL286485A (en) Pi4-kinase inhibitors and methods of using the same
DK4288456T3 (da) Anti-met-antistoffer og anvendelser deraf
IL284880A (en) Liver-specific inducible promoters and methods of use thereof